Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model - a computational study

By Gozzo A.   Lesieur D.   Duriez P.   Fruchart J.-C.   Teissier E.  

Free Radical Biology and Medicine, Vol. 26, Iss. 11, 1999-06 ,pp. : 1538-1543

Elsevier

Access to resources Recommend Favorite

Structure-Activity Relationships of Human Urotensin II and Related Analogues on Rat Aortic Ring Contraction

By Labarrère† Patricia   Chatenet† David   Leprince† Jérôme   Marionneau† Céline   Loirand Gervaise   Tonon Marie-Christine   Dubessy Christophe   Scalbert Elizabeth   Pfeiffer Bruno   Renard Pierre   Calas Bernard   Pacaud Pierre   Vaudry Hubert  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Iss. 2, 2003-04 ,pp. : 77-88

Informa Healthcare

Access to resources Recommend Favorite

Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth - structure-activity relationships for betulinic acid analogues

By Ziegler H.L.   Franzyk H.   Sairafianpour M.   Tabatabai M.   Tehrani M.D.   Bagherzadeh K.   Hagerstrand H.   Staerk D.   Jaroszewski J.W.  

Bioorganic and Medicinal Chemistry, Vol. 12, Iss. 1, 2004-01 ,pp. : 119-127

Elsevier

Access to resources Recommend Favorite

Lactoferrin and bone; structure–activity relationships

By Cornish J.   Palmano K.   Callon K.E.   Watson M.   Lin J.M.   Valenti P.   Naot D.   Grey A.B.   Reid I.R.  

Biochemistry and Cell Biology, Vol. 84, Iss. 3, 2006-06 ,pp. : 297-302

NRC Research Press

Access to resources Recommend Favorite

Structure-activity and structure-metabolism relationships of HIV protease inhibitors containing the 3-hydroxy-2-methylbenzoyl-allophenylnorstatine structure

By Mimoto T.   Terashima K.   Nojima S.   Takaku H.   Nakayama M.   Shintani M.   Yamaoka T.   Hayashi H.  

Bioorganic and Medicinal Chemistry, Vol. 12, Iss. 1, 2004-01 ,pp. : 281-293

Elsevier

Access to resources Recommend Favorite